LEVERKUSEN, Germany, Dec. 22 -- Bayer, a pharmaceutical and life sciences company, issued the following news release: * * * Finerenone approved in Japan for treatment of patients with chronic heart failure MHLW approves finerenone in Japan for chronic heart failure, introducing a new therapeutic option for patients with chronic heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e. mildly reduced or preserved LVEF / Finerenone (Kerendia(TM)) is the first drug targeti  more

WASHINGTON, Dec. 20 (TNSdok) -- The Maine Public Utilities Commission has opened a second round of bidding for large-scale energy projects designed to unlock the renewable potential of the state's northern reaches. The "Request for Proposals for Renewable Energy Generation and Transmission Projects Pursuant to the Northern Maine Renewable Energy Development Program, 35-A M.R.S. Sec. 3209-I" (Docket No. 2025-00361) seeks to connect northern Maine to the regional power grid. This initiative origi  more

PORTLAND, Maine, Dec. 21 -- The University of Maine School of Law issued the following news: * * * Supporting Maine's Vulnerable: Maine Law's Refugee and Human Rights Clinic Serves Hundreds of Immigrants with Detention Consultations, Community Outreach, and Legal Training Mainers have long shared a strong sense of fairness, a responsibility to one another, and a commitment to due process as provided by the U.S. Constitution. At the University of Maine School of Law (Maine Law), these princip  more